Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amobarbital to Prevent Post-Traumatic Osteoarthritis in Fractured Ankle Joints
NCT04589611Phase 2Terminated
- Sponsor
- Marsh
- Start
- Jul 2022
- Primary completion
- Dec 2023
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amobarbital in Post-traumatic osteoarthritis (PTOA), sponsored by Marsh. Started Jul 2022; status: terminated.
02
Drugs
amobarbital
03
Conditions
Post-traumatic osteoarthritis (PTOA)
Beyond the preview
Go deeper on NCT04589611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589611.